Approval · Notice of Compliance 4954 · 1995
CATAPRES: Notice of Compliance 4954
Issued June 26, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4954
- Date
- June 26, 1995
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Antihypertensive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CATAPRES | Not yet assigned | — |
Medicinal ingredients
- CLONIDINE HYDROCHLORIDE 0.1 MG per TAB
- CLONIDINE HYDROCHLORIDE 0.2 MG per TAB